Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07398157 · ClinicalTrials.gov registry record · NA

Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease

A NA study, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
24
Enrollment target

NCT07398157 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 24 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07398157, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect useful brain signals? Find out if these brain signals can be related to movement and/or sleep symptoms. * How to use these brain signals to tailor adaptive deep brain stimulation settings for movement and/or sleep symptoms Researchers will compare study derived adaptive DBS settings to subject's clinically programmed continuous DBS settings to see which is better at treating patients PD symptoms.

Interventions

  • DEVICE Medtronic Percept Deep Brain Stimulation (cDBS)
  • DEVICE Medtronic Percept Deep Brain Stimulation (daytime aDBS)
  • DEVICE Medtronic Percept Deep Brain Stimulation (nighttime aDBS)

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-04-09
Est. Completion 2031-11-30
Phase NA

What the Registry Record Tells You About NCT07398157

The ClinicalTrials.gov registry entry for NCT07398157 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Medtronic Percept Deep Brain Stimulation (cDBS) is the first listed.

NCT07398157 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07398157 about?

NCT07398157 is a clinical study titled "Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease". The purpose of this study is to test a new way to treat Parkinson's disease (PD). Subjects will be implanted with deep brain stimulator (DBS) devices and electrodes placed under the scalp. The main questions it aims to answer are: * Is there a less invasive method to collect useful brain signals? ...

What is the current status of trial NCT07398157?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-04-09. Estimated completion is 2031-11-30.

What interventions are being tested in trial NCT07398157?

The interventions under investigation include: Medtronic Percept Deep Brain Stimulation (cDBS) (DEVICE), Medtronic Percept Deep Brain Stimulation (daytime aDBS) (DEVICE), Medtronic Percept Deep Brain Stimulation (nighttime aDBS) (DEVICE).

Who is sponsoring clinical trial NCT07398157?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.